IDH1 and neoplasm: Followed by further examination and verification, we confirmed clomifene, an effective and low-cost medication for ovulation induction, as a novel inhibitor of mutant IDH1, which could reduce the cellular and tumor levels of D-2HG, showing dramatically on-target activity both in vitro and in vivo.